PRTA
Prothena Corp Public Ltd CoCompany with tickers: PRTA
CIK
1559053
CUSIP
G72800108
Shares Outstanding
52,353,237
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,828,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $68,409,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $50,811,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-65,581,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-60,195,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.12 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-1.12 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |